TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
JBJ Medicine etc. AB
Closing information (x1000 DKK)
Closing information | 2023/09 | 2022/09 | 2021/09 |
Turnover | 0 | 27 | 0 |
Financial expenses | 0 | 0 | 0 |
Earnings before taxes | -17 | 7 | -12 |
EBITDA | -17 | 7 | -12 |
Total assets | 39 | 65 | 49 |
Current assets | 16 | 41 | 9 |
Current liabilities | 6 | 23 | 12 |
Equity capital | 32 | 42 | 36 |
- share capital | 32 | 34 | 36 |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Solvency | 82.1% | 64.6% | 73.5% |
Turnover per employee | 0 | 27 | 0 |
Profit as a percentage of turnover | 25.9% | ||
Return on assets (ROA) | -43.6% | 10.8% | -24.5% |
Current ratio | 266.7% | 178.3% | 75.0% |
Return on equity (ROE) | -53.1% | 16.7% | -33.3% |
Change turnover | -26 | 27 | -14 |
Change turnover % | -100% | -100% | |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.